세계의 눈 알레르기 치료 시장 보고서(2025년)
Eye Allergy Therapeutics Global Market Report 2025
상품코드 : 1810894
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

눈 알레르기 치료 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년 연평균 성장률(CAGR)은 6.1%로 41억 달러에 달할 전망입니다. 예측 기간 동안 성장의 원동력은 노인 인구 증가, 생물학적 치료법의 채택 확대, 안과 연구에 대한 자금 지원 증가, 안구 알레르기 증상에 대한 인식 증가, 약물 전달 기술의 발전 등에 기인할 것으로 예측됩니다. 이 기간 동안 주요 동향으로는 개인 맞춤형 의료의 발전, 서방형 제제의 혁신, 디지털 진단 도구의 통합, 생물학적 치료의 발전, 새로운 비침습적 치료 접근법 등이 있습니다.

눈 알레르기 유병률 증가는 향후 몇 년 동안 눈 알레르기 치료 시장의 성장을 견인할 것으로 예측됩니다. 눈 알레르기는 면역체계가 알레르겐에 반응하여 눈에 염증과 염증을 유발하여 발생합니다. 눈 알레르기 증가는 환경오염의 악화가 주요 원인으로, 공기 중 알레르겐에 노출될 기회가 증가하여 더 많은 알레르기 반응을 일으킵니다. 눈 알레르기 치료는 염증을 억제하고 가려움증과 충혈을 완화하며 알레르기 반응을 예방함으로써 이러한 알레르기를 관리하고 효과적인 증상 완화를 설명합니다. 예를 들어, 2025년 5월 미국의 생물 의학 자원인 국립의학도서관은 눈 알레르기(OA)가 조사 대상의 49.3%(n=207)를 차지했고, 계절성 알레르기성 결막염(SAC)이 90.3%를 차지했으며, 주로 14세(23.4%)와 여성(58.8%)이 많았다고 보고했습니다. 따라서 눈 알레르기 유병률 증가는 눈 알레르기 치료 시장의 확대에 박차를 가하고 있습니다.

눈 알레르기 치료 시장의 주요 시장 진출기업들은 가려움증 완화 치료제를 포함한 혁신적인 제품에 집중하고 있으며, 빠른 증상 완화, 환자 편의성 향상, 시판 의약품을 통한 접근성 향상에 주력하고 있습니다. 눈 알레르기 가려움증 완화 치료는 특히 알레르기성 눈 반응으로 인한 가려움증을 대상으로 합니다. 예를 들어, 2024년 8월 인도 글렌마크제약(Glenmark Pharmaceuticals Limited)은 1일 2회 복용하는 Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1%(OTC)를 출시하였습니다. 이 제제는 눈의 가려움증, 충혈, 눈물 등의 알레르기성 결막염 증상을 빠르고 지속적으로 개선합니다. 이 OTC 제품은 셀프 케어 제품에 대한 수요 증가에 대응하고, 아이케어 시장에서 소비자의 접근성을 확대하기 위한 것입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 코로나재난과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 전략

제36장 부록

LSH
영문 목차

영문목차

Eye allergy therapeutics are treatments designed to alleviate symptoms caused by allergic reactions in the eyes, such as itching, redness, swelling, and tearing. These treatments work by addressing the allergic response and may involve the use of antihistamines, mast cell stabilizers, or corticosteroids.

The primary drug categories for eye allergy treatments include antihistamines, mast cell stabilizers, dual-action agents, corticosteroids, decongestants, immunotherapy, and others. Antihistamines function by blocking histamine receptors, helping to reduce itching, redness, and swelling linked to allergies. Common types of eye allergies include seasonal allergic conjunctivitis (SAC), perennial allergic conjunctivitis (PAC), vernal keratoconjunctivitis (VKC), atopic keratoconjunctivitis (AKC), and giant papillary conjunctivitis. These medications can be administered through various routes such as topical, oral, injectable, ocular, and systemic methods. Distribution occurs via hospital pharmacies, retail pharmacies, online pharmacies, among other channels. The main end users encompass hospitals, clinics, homecare providers, pharmacies, and research institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The eye allergy therapeutics market research report is one of a series of new reports from The Business Research Company that provides eye allergy therapeutics market statistics, including the eye allergy therapeutics industry global market size, regional shares, competitors with the eye allergy therapeutics market share, detailed eye allergy therapeutics market segments, market trends, and opportunities, and any further data you may need to thrive in the eye allergy therapeutics industry. This eye allergy therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The eye allergy therapeutics market size has grown strongly in recent years. It will grow from $3.04 billion in 2024 to $3.23 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. Several factors contributed to growth during the historic period, including the increasing prevalence of allergic conjunctivitis, greater awareness of eye allergies, higher levels of urban pollution, improved availability of advanced treatments, and enhancements in healthcare infrastructure.

The eye allergy therapeutics market size is expected to see strong growth in the next few years. It will grow to$4.10 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. Growth in the forecast period is expected to be driven by the expanding elderly population, greater adoption of biologic treatments, increased funding for ophthalmic research, heightened awareness of eye allergy symptoms, and progress in drug delivery technologies. Key trends during this time will include developments in personalized medicine, innovations in sustained-release drug formulations, the integration of digital diagnostic tools, advances in biologic therapies, and new non-invasive treatment approaches.

The increasing prevalence of eye allergies is expected to drive the growth of the eye allergy therapeutics market in the coming years. Eye allergies occur when the immune system reacts to allergens, causing inflammation and irritation in the eyes. The rise in eye allergy cases is largely attributed to worsening environmental pollution, which increases exposure to airborne allergens and triggers more allergic responses. Eye allergy therapeutics help manage these allergies by reducing inflammation, relieving itching and redness, and preventing allergic reactions to offer effective symptom relief. For example, in May 2025, the National Library of Medicine, a US-based biomedical resource, reported that ocular allergy (OA) affected 49.3% (n=207) of cases studied, with seasonal allergic conjunctivitis (SAC) making up 90.3%, primarily among 14-year-olds (23.4%) and females (58.8%). Hence, the growing incidence of eye allergies is fueling the expansion of the eye allergy therapeutics market.

Key players in the eye allergy therapeutics market are focusing on innovative products, including itch relief treatments, to provide quicker symptom relief, improve patient comfort, and increase accessibility through over-the-counter options. Eye allergy itch relief therapeutics specifically target itching caused by allergic eye reactions. For instance, in August 2024, Glenmark Pharmaceuticals Limited, an India-based company, introduced Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% (OTC), designed for twice-daily use. This formulation delivers fast and lasting relief from symptoms of allergic conjunctivitis such as itching, redness, and watery eyes. The OTC availability caters to the rising demand for self-care products and broadens consumer access within the eye care market.

In July 2023, Harrow Inc., a US-based ophthalmic pharmaceutical provider, acquired the Canadian and US ophthalmic portfolio from Santen Pharmaceutical Co. Ltd. for an undisclosed amount. This acquisition expanded Harrow's presence in North America and added established eye care brands to its portfolio. The move supports Harrow's ambition to become a leading supplier of comprehensive ophthalmic solutions. Santen Pharmaceutical Co. Ltd. is a Japan-based manufacturer specializing in eye allergy therapeutics.

Major players in the eye allergy therapeutics market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, GlaxoSmithKline plc, Teva Pharmaceutical Industries Limited, Regeneron Pharmaceuticals Inc., Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Hikma Pharmaceuticals plc, Santen Pharmaceutical Co. Ltd., Zydus Lifesciences Limited, Stallergenes Greer Ltd., HAL Allergy B.V., Ocular Therapeutix Inc., Tarsus Pharmaceuticals Inc., Nicox S.A.

North America was the largest region in the eye allergy therapeutics market in 2024. The regions covered in eye allergy therapeutics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the eye allergy therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The eye allergy therapeutics market consists of sales of artificial tears and lubricants, natural or herbal remedies, and non-steroidal anti-inflammatory drugs. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Eye Allergy Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on eye allergy therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for eye allergy therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The eye allergy therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Eye Allergy Therapeutics Market Characteristics

3. Eye Allergy Therapeutics Market Trends And Strategies

4. Eye Allergy Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Eye Allergy Therapeutics Growth Analysis And Strategic Analysis Framework

6. Eye Allergy Therapeutics Market Segmentation

7. Eye Allergy Therapeutics Market Regional And Country Analysis

8. Asia-Pacific Eye Allergy Therapeutics Market

9. China Eye Allergy Therapeutics Market

10. India Eye Allergy Therapeutics Market

11. Japan Eye Allergy Therapeutics Market

12. Australia Eye Allergy Therapeutics Market

13. Indonesia Eye Allergy Therapeutics Market

14. South Korea Eye Allergy Therapeutics Market

15. Western Europe Eye Allergy Therapeutics Market

16. UK Eye Allergy Therapeutics Market

17. Germany Eye Allergy Therapeutics Market

18. France Eye Allergy Therapeutics Market

19. Italy Eye Allergy Therapeutics Market

20. Spain Eye Allergy Therapeutics Market

21. Eastern Europe Eye Allergy Therapeutics Market

22. Russia Eye Allergy Therapeutics Market

23. North America Eye Allergy Therapeutics Market

24. USA Eye Allergy Therapeutics Market

25. Canada Eye Allergy Therapeutics Market

26. South America Eye Allergy Therapeutics Market

27. Brazil Eye Allergy Therapeutics Market

28. Middle East Eye Allergy Therapeutics Market

29. Africa Eye Allergy Therapeutics Market

30. Eye Allergy Therapeutics Market Competitive Landscape And Company Profiles

31. Eye Allergy Therapeutics Market Other Major And Innovative Companies

32. Global Eye Allergy Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Eye Allergy Therapeutics Market

34. Recent Developments In The Eye Allergy Therapeutics Market

35. Eye Allergy Therapeutics Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기